← Open Payments lookup

MEGAN CARAVAS: Open Payments

NPI 1740875459 · CHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,056 in 149 payments from 20 companies in 2025. Trend: 2023 $2,617 · 2024 $2,069 · 2025 $3,056

Food & beverage: $3,056
CompanyPaymentsAmount
ABBVIE INC.25$552
Takeda Pharmaceuticals U.S.A., Inc.36$477
Janssen Biotech, Inc.19$370
QOL Medical, LLC11$314
GENZYME CORPORATION7$210
Madrigal Pharmaceuticals5$177
PFIZER INC.8$163
Ipsen Biopharmaceuticals, Inc7$158
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$138
Ardelyx, Inc.8$137

Products named: TREMFYA, Sucraid, ENTYVIO, DUPIXENT, EOHILIA, REZDIFFRA, RINVOQ, IQIRVO.

Industry payments across VA — which companies pay providers there.